IRIS
SPINA, Edoardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.005
EU - Europa 17.346
AS - Asia 9.124
SA - Sud America 3.213
Continente sconosciuto - Info sul continente non disponibili 438
AF - Africa 260
OC - Oceania 26
Totale 48.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.612
RU - Federazione Russa 8.273
SG - Singapore 3.892
BR - Brasile 2.783
CN - Cina 2.493
IE - Irlanda 2.092
SE - Svezia 1.692
IT - Italia 1.448
HK - Hong Kong 1.001
UA - Ucraina 907
DE - Germania 906
FR - Francia 540
VN - Vietnam 524
FI - Finlandia 456
GB - Regno Unito 392
IN - India 343
PL - Polonia 214
CA - Canada 183
AR - Argentina 152
BD - Bangladesh 138
MX - Messico 109
TR - Turchia 92
IQ - Iraq 87
NL - Olanda 87
ZA - Sudafrica 73
ID - Indonesia 72
EC - Ecuador 68
BE - Belgio 62
JP - Giappone 57
CO - Colombia 56
ES - Italia 56
PK - Pakistan 52
UZ - Uzbekistan 50
VE - Venezuela 47
MA - Marocco 46
CL - Cile 44
AT - Austria 42
EE - Estonia 32
AE - Emirati Arabi Uniti 31
PH - Filippine 30
SA - Arabia Saudita 27
DZ - Algeria 26
KE - Kenya 23
MY - Malesia 23
AZ - Azerbaigian 22
EG - Egitto 22
TN - Tunisia 22
UY - Uruguay 22
CR - Costa Rica 21
NP - Nepal 20
CI - Costa d'Avorio 19
JM - Giamaica 19
JO - Giordania 19
AU - Australia 18
KZ - Kazakistan 18
LT - Lituania 17
OM - Oman 17
AL - Albania 16
PY - Paraguay 16
PE - Perù 15
CZ - Repubblica Ceca 14
GR - Grecia 14
IL - Israele 13
BG - Bulgaria 12
CH - Svizzera 12
HN - Honduras 12
IR - Iran 11
LB - Libano 11
TH - Thailandia 11
DO - Repubblica Dominicana 9
KG - Kirghizistan 9
RS - Serbia 9
AM - Armenia 8
BO - Bolivia 8
LV - Lettonia 8
PS - Palestinian Territory 8
RO - Romania 8
SN - Senegal 8
KR - Corea 7
PA - Panama 7
SV - El Salvador 7
EU - Europa 6
GE - Georgia 6
NI - Nicaragua 6
TW - Taiwan 6
BN - Brunei Darussalam 5
ET - Etiopia 5
HR - Croazia 5
PR - Porto Rico 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
KH - Cambogia 4
NZ - Nuova Zelanda 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
BY - Bielorussia 3
DK - Danimarca 3
GT - Guatemala 3
HU - Ungheria 3
Totale 47.925
Salva come PNG Salva come JPEG
Città #
Moscow 2.640
Ashburn 2.159
Singapore 2.129
Dublin 2.079
Jacksonville 1.750
Dallas 1.739
Chandler 1.510
Hong Kong 997
Beijing 905
Nyköping 742
Council Bluffs 644
San Jose 585
Princeton 398
The Dalles 398
Cambridge 361
Dearborn 359
Los Angeles 352
Lauterbourg 348
Des Moines 286
New York 248
Medford 245
Messina 234
Boardman 229
São Paulo 213
Buffalo 198
Warsaw 196
Ann Arbor 194
Ho Chi Minh City 170
Santa Clara 139
Hyderabad 136
Munich 136
Tianjin 126
Wilmington 124
Hanoi 108
Houston 101
Milan 99
Guangzhou 98
Lancaster 94
Redondo Beach 94
Rome 87
Orem 86
Rio de Janeiro 86
Woodbridge 77
Jinan 74
Seattle 74
Frankfurt am Main 69
Turku 68
Belo Horizonte 66
Atlanta 64
Shenyang 64
Bremen 63
San Mateo 61
Brussels 57
Montreal 55
Brasília 53
Nanjing 48
Tokyo 47
Curitiba 46
Pune 46
Columbus 45
Denver 45
Catania 43
Tashkent 43
Chennai 42
San Francisco 42
Baghdad 38
Brooklyn 38
Chicago 38
Hangzhou 37
Johannesburg 36
Boston 34
Hebei 34
Porto Alegre 34
Campinas 33
London 33
Phoenix 33
Haikou 32
Helsinki 32
Mexico City 31
Nuremberg 31
Shenzhen 30
Zhengzhou 30
Norwalk 27
Stockholm 27
Ningbo 26
Shanghai 26
Taizhou 26
Toronto 26
Washington 26
Dhaka 25
Guarulhos 25
Haiphong 25
Mumbai 25
Recife 25
Vienna 25
Amsterdam 24
Guayaquil 23
Manchester 23
Salvador 23
Baku 22
Totale 26.137
Salva come PNG Salva come JPEG
Nome #
Clinically Relevant Drug Interactions Between Statins and Antidepressants 470
Efficacia di un trattamento aggiuntivo con olanzapina nel disturbo ossessivo-compulsivo resistente agli SSRI 446
Drug-drug interactions between psychotropic medications and oral contraceptives 413
Rabeprazole and psychiatric symptoms. 366
Cutis verticis gyrata primitiva o pachidermia verticis gyrata: contributo clinico-istologico 339
Serenoa repens as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report 307
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 291
Adverse Drug Reactions in Hospitalized patients: results of the FORWARD (Facilitation of reporting in hospital Ward) study. 273
Short-term memory loss associated with rosuvastatin. 268
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 266
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 256
A molecular pathway analysis informs the genetic background at risk for schizophrenia. 252
Vortioxetine on Cognition in Schizophrenia: A Pilot Study 248
6-Mer Hyaluronan Oligosaccharides ModulateNeuroinflammation and a-Synuclein Expression inNeuron-Like SH-SY5Y Cells 237
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 233
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 229
Acute Cerebellar Ataxia Following Meningococcal Group C Conjugate Vaccination 223
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 221
Aripiprazolo in bambini con ADHD in comorbidità con Disturbo da Tic 217
Confronto Teofillina-Doxofillina nella risoluzione del broncospasmo 216
Management of women with epilepsy: from preconception to post-partum 209
"Valproic acid-amitriptyline interaction in man 204
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 202
Augmentation con Lamotrigina in pazienti con schizofrenia resistente in trattamento con Clozapina 199
6-MERS HYALURONAN OLIGOSACCHARIDES STIMULATE INFLAMMATORY RESPONSE IN NEURONAL-LIKE DIFFERENTIATED SH-SY5Y NEUROBLASTOMA CELLS 198
ANTITHETIC ACTION OF HYALURONAN 6-MER IN UNDIFFERENTIATED AND DIFFERENTIATED SH-SY5Y CELLS 195
Duloxetine in Psychiatric Disorders: Expansions Beyond Major Depression and Generalized Anxiety Disorder 195
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 195
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 194
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 192
A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone. 191
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 190
Low-dose of bergamot-derived polyphenolic fraction (BPF) did not improve metabolic parameters in second generation antipsychotics-treated patients: Results from a 60-days open-label study 189
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 188
ECG parameters in children and adolescents treated with aripiprazole and risperidone 188
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 188
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity 187
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder 187
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 186
Antidepressant use in the elderly: The role of pharmacodynamics and pharmacokinetics in drug safety 186
Antidepressant effect of hypericum perforatum extract on behaviour and neurogenesis in chronic corticosterone-treated mice. 184
ABCB1 polymorphisms influence steady state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. 182
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 182
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 181
Augmentation of clozapine with agomelatine in partial-responder schizophrenia: A 16-week, open-label, uncontrolled pilot study 177
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients 176
Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescent. 176
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 174
Aripiprazole enhances the antidepressant effect of fluoxetine in mice. 174
Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications 173
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. 172
Real world use of biological drugs in patients with psoriasis/psoriatic arthritis: a retrospective, population-based study from Southern Italy in the years 2010-2014 171
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 170
Aripiprazole in Children with Multiple-complex Developmental Disorder (McDD): a case series. 170
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 169
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 169
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study. 167
A double-blind comparative study of bromperidol versus halperidol in schizophrenic patients 167
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 167
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 166
Aripiprazole enhances the antidepressat effect of fluoxetine in mice. 166
Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study. XVII Congresso Nazionale della Società Italiana di Neuropsicofarmacologia, Cagliari 22-25 Settembre 2010, p. 47. 166
Aripiprazole augmentation of serotinin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study 166
Efficacia e tollerabilità della quetiapina vs. clozapina in pazienti anziani parkinsoniani con psicosi dopaminergica. 166
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction 165
A pharmacokinetic-pharmacodynamic method for predicting warfarin maintenance dose: preliminary results 165
Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs. 165
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 165
AN ENDOCRINOLOGIC STUDY OF PATIENTS WITH PRIMARY-CUTIS-VERTICIS GYRATA 164
Effetto di un trattamento con risperidone o olanzapina sui livelli serici di prolattina in bambini e adolescenti con patologie psichiatriche. 164
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 164
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. 163
Tossicità cardiovascolare degli antipsicotici atipici in età evolutiva 161
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 160
No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population 159
5-HT2A and 5-HT2C receptor polymorphisms and psychotic symptoms in Alzheimer's disease 159
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 159
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial. 158
Drug-induced urinary retention: an analysis of a national spontaneous adverse drug reaction reporting database 155
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 153
Early atypical injection-site reactions to COVID-19 vaccine: a case series 152
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 152
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. 151
“Augmentation con Duloxetina vs. placebo in un campione di schizofrenici partial responders in trattamento stabilizzato con antipsicotici atipici”. 151
Uso dell’Aripiprazolo in bambini con Multiple-complex Developmental Disorder (McDD). 151
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with Attention Deficit Hyperactivity Disorder 151
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 151
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 151
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. 150
Red Yeast Rice (RYR) supplementation in patients treated with second-generation antipsychotics. 149
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 149
PARKINSONISMO ED INIBITORI SELETTIVI DEL REUPTAKE DELLA SEROTONINA 148
Augmentation of Clozapine With Ziprasidone in Refractory Schizophrenia: A Double-Blind, Placebo-Controlled Study. 148
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 148
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies 148
Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders 147
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model. 147
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years 147
Prescribing pattern of antiepileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-2007 147
Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olazapine and risperidone I patients with psychotic disorders 147
Totale 19.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.564
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.183 0 224 30 75 49 23 132 113 81 446 291 719
2022/20235.860 506 407 217 477 518 540 51 343 2.536 28 175 62
2023/20241.660 121 244 108 167 167 334 70 102 26 163 19 139
2024/20257.210 96 95 155 399 380 219 137 1.636 1.923 445 578 1.147
2025/202620.855 903 1.405 1.795 1.467 1.586 4.503 2.395 2.465 2.561 890 418 467
2026/20273.164 996 2.168 0 0 0 0 0 0 0 0 0 0
Totale 48.412